Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for early intervention in acute stroke

G W Albers1

  • 1Department of Neurology and the Stanford Stroke Center, Stanford University Medical Center, California 94304-1705, USA.

The American Journal of Cardiology
|August 28, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive Venous Outflow Predicts Functional Outcomes in Patients with Acute Ischemic Stroke Treated by Thrombectomy.

AJNR. American journal of neuroradiology·2023
Same author

Tissue at Risk and Ischemic Core Estimation Using Deep Learning in Acute Stroke.

AJNR. American journal of neuroradiology·2021
Same author

Hypoperfusion intensity ratio correlates with angiographic collaterals in acute ischaemic stroke with M1 occlusion.

European journal of neurology·2020
Same author

Thrombectomy with Conscious Sedation Compared with General Anesthesia: A DEFUSE 3 Analysis.

AJNR. American journal of neuroradiology·2019
Same author

Low yield of clinically significant transesophageal echocardiographic findings in patients with lacunar stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Multi-Center Study of Diffusion-Weighted Imaging in Coma After Cardiac Arrest.

Neurocritical care·2015
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Rapid treatment is crucial for ischemic stroke, a condition caused by reduced blood flow. Emerging therapies like tissue plasminogen activator (t-PA) and neuroprotective agents show promise but require early administration for effectiveness.

Area of Science:

  • Neurology
  • Cerebrovascular Medicine
  • Emergency Medicine

Background:

  • Ischemic stroke results from sudden cerebral blood flow reduction, often due to artery thrombosis.
  • Stroke symptoms vary based on the affected brain region, and many patients delay seeking medical attention.
  • Current treatment options are limited, with few patients receiving timely thrombolytic therapy.

Purpose of the Study:

  • To review the current understanding and treatment of ischemic stroke.
  • To highlight the potential of emerging neuroprotective agents and combination therapies.
  • To emphasize the need for improved public and professional education on stroke recognition and management.

Main Methods:

  • Review of recent advancements in understanding ischemic stroke pathophysiology.

Related Experiment Videos

  • Analysis of clinical trial data for thrombolytic and neuroprotective therapies.
  • Discussion of the challenges and future directions in acute stroke treatment.

    • Main Results:

    • Intravenous tissue plasminogen activator (t-PA) is effective within 3 hours of stroke onset but underutilized.
    • Neuroprotective agents show promise in preclinical and early clinical studies.
    • Combined thrombolytic and neuroprotective strategies are anticipated for future stroke management.

    Conclusions:

    • Early administration of t-PA and neuroprotective agents is critical for improving outcomes in ischemic stroke.
    • Further research and development of neuroprotective strategies are ongoing.
    • Enhanced public and professional education is essential for timely stroke recognition, evaluation, and treatment.